Skip to main content

Mata Nathan L.'s Form 4 filing

Belite Bio, Inc (BLTE) · filed May 8, 2026

Accession no.
0001193125-26-214820
Filed
May 8, 2026
Trade date
May 7, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions. Open-market sales total $102.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mata Nathan L.CIK 0002013987Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 7, 2026American depositary shareSSaleDisposed−226$152.45F3−$34,453.7440Direct
May 7, 2026American depositary shareSSaleDisposed−428$153.56F4−$65,723.6812Direct
May 7, 2026American depositary shareSSaleDisposed−3$154.61−$463.839Direct
May 7, 2026American depositary shareSSaleDisposed−9$155.25F5−$1,397.250Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Represents the weighted average price of shares sold at prices that ranged from $152.35 to $152.68. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average price of shares sold at prices that ranged from $153.1 to $153.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average price of shares sold at prices that ranged from $155.18 to $155.29. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)